Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

002675.SZ · SHZ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Market CapCN¥10CN¥15CN¥13CN¥13
- CashCN¥1CN¥1CN¥1CN¥1
+ DebtCN¥1CN¥1CN¥1CN¥1
Enterprise ValueCN¥10CN¥15CN¥13CN¥13
RevenueCN¥3CN¥3CN¥4CN¥4
% Growth-12.4%-8.6%-8.4%
Gross ProfitCN¥1CN¥1CN¥2CN¥2
% Margin47%41.3%42.8%40.6%
EBITDACN¥0CN¥1CN¥1CN¥1
% Margin15.1%15.6%18.8%18.6%
Net IncomeCN¥0CN¥0CN¥0CN¥0
% Margin6.4%6.4%8.6%3.9%
EPS Diluted0.2230.2540.380.189
% Growth-12.4%-33.1%101.2%
Operating Cash FlowCN¥0CN¥0CN¥1CN¥1
Capital Expenditures-CN¥0-CN¥1-CN¥0-CN¥1
Free Cash Flow-CN¥0-CN¥0CN¥1CN¥0
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (002675.SZ) Financial Statements & Key Stats | AlphaPilot